SAE1 and hepatocellular carcinoma: Additionally, and with clinical relevance, we demonstrated that the overexpression of SAE1 is associated with poor prognosis, as evident in the shorter overall or disease-specific, and relapse-free survival time of patients with high expression of SAE1 in our HCC cohort and freely accessible larger HCC cohorts.